🔐 Secure Payment Guaranteed
Safe checkout with trusted global payment methods.
🌟 Why Choose Infinity Market Research?
At Infinity Market Research, we dont just deliver data — we deliver clarity, confidence, and competitive edge.
In a world driven by insights, we help businesses unlock the infinite potential of informed decisions.
Here why global brands, startups, and decision-makers choose us:
Industry-Centric Expertise
With deep domain knowledge across sectors — from healthcare and technology to manufacturing and consumer goods — our team delivers insights that matter.
Custom Research, Not Cookie-Cutter Reports
Every business is unique, and so are its challenges. Thats why we tailor our research to your specific goals, offering solutions that are actionable, relevant, and reliable.
Data You Can Trust
Our research methodology is rigorous, transparent, and validated at every step. We believe in delivering not just numbers, but numbers that drive real impact.
Client-Centric Approach
Your success is our priority. From first contact to final delivery, our team is responsive, collaborative, and committed to your goals — because you re more than a client; you re a partner.
Recent Reports
Water-based Primers Market
Solvent Based Primers Market
Global PD-1 and PDL-1 Inhibitors Market Growth 2025-2031
Sep 2025
Healthcare
Pages: 109
LPI10585
The global PD-1 and PDL-1 Inhibitors market size is predicted to grow from US$ 47240 million in 2025 to US$ 71940 million in 2031; it is expected to grow at a CAGR of 7.3% from 2025 to 2031.
Explore this report in detail? Download a free sample copy
Download Free Sample Report
PD-1 inhibitors and PD-L1 inhibitors are a group of checkpoint inhibitors being developed for the treatment of cancer. PD-1 and PD-L1 are both proteins present on the surface of cells. Immune checkpoint inhibitors such as these are emerging as a front-line treatment for several types of cancer.
North America is the largest consumption place, with a consumption market share nearly 60.40% in 2019. Following North America, Europe is the second largest consumption place with the consumption market share of 20.66%.Market competition is intense. Merck, Bristol-Myers Squibb, Roche, AstraZeneca, Ono Pharmaceutical etc. are the leaders of the industry.
Infinity Market Research newest research report, the ?PD-1 and PDL-1 Inhibitors Industry Forecast? looks at past sales and reviews total world PD-1 and PDL-1 Inhibitors sales in 2024, providing a comprehensive analysis by region and market sector of projected PD-1 and PDL-1 Inhibitors sales for 2025 through 2031. With PD-1 and PDL-1 Inhibitors sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world PD-1 and PDL-1 Inhibitors industry.
This Insight Report provides a comprehensive analysis of the global PD-1 and PDL-1 Inhibitors landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on PD-1 and PDL-1 Inhibitors portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global PD-1 and PDL-1 Inhibitors market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for PD-1 and PDL-1 Inhibitors and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global PD-1 and PDL-1 Inhibitors.
This report presents a comprehensive overview, market shares, and growth opportunities of PD-1 and PDL-1 Inhibitors market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Pembrolizumab
Nivolumab
Atezolizumab
Durvalumab
Avelumab
Segmentation by Application:
Stomach Cancer
Liver Cancer
Kidney Ccancer
Bladder Cancer
Cervical Cancer
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration.
GlaxoSmithKline plc
Bristol-Myers Squibb Company
Arcus Biosciences, Inc.
Agenus Inc
F. Hoffmann-La Roche Ltd
Astra Zeneca PLC
Beigene Ltd
Incyte Corporation
Biocad
CStone Pharmaceuticals
Ono Pharmaceutical
Merck
Shanghai Junshi Bioscience Co. Ltd
Shanghai Henlius Biotech, Inc.
Jiangsu HengRui Medicine Co., Ltd.
Key Questions Addressed in this Report
What is the 10-year outlook for the global PD-1 and PDL-1 Inhibitors market?
What factors are driving PD-1 and PDL-1 Inhibitors market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do PD-1 and PDL-1 Inhibitors market opportunities vary by end market size?
How does PD-1 and PDL-1 Inhibitors break out by Type, by Application?
PD-1 and PDL-1 Inhibitors Market Scope
| Report Attribute | Details |
|---|---|
| Market Size (Start Year) | USD XX Million |
| Market Size (End Year) | USD XX Million |
| Compound Annual Growth Rate (CAGR) | USD XX Million |
| Forecast Period | USD XX Million |
| Base Year | USD XX Million |
| Historical Data | USD XX Million |
| Key Players | USD XX Million |
REPORT COVERAGE
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
SEGMENT COVERED
By component, deployment, organization size, application, and industry.
REGIONAL SCOPE
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
COUNTRY SCOPE
Includes key countries across all major regions.
📘 Frequently Asked Questions
1. What is the market size of Global PD-1 and PDL-1 Inhibitors Market?
Answer: The global PD-1 and PDL-1 Inhibitors market size is predicted to grow from US$ 47240 million in 2025 to US$ 71940 million in 2031; it is expected to grow at a CAGR of 7.3% from 2025 to 2031.
2. Which regions are analyzed in the Global PD-1 and PDL-1 Inhibitors Market report?
Answer: The Global PD-1 and PDL-1 Inhibitors Market report covers major regions such as North America, Europe, Middle East & Africa. Each region is analyzed for trends, opportunities, and market dynamics.
3. What methodology is used for forecasting of Global PD-1 and PDL-1 Inhibitors Market?
Answer: The Global PD-1 and PDL-1 Inhibitors Market report uses a mix of primary research, secondary data, and expert analysis to build its forecasts. Models include both qualitative and quantitative approaches.
4. Are emerging markets analyzed separately in the Global PD-1 and PDL-1 Inhibitors Market?
Answer: Yes, the Global PD-1 and PDL-1 Inhibitors Market report highlights high-growth emerging regions with dedicated insights. These include untapped opportunities, risks, and potential for expansion.
5. Does the report include competitive benchmarking of Global PD-1 and PDL-1 Inhibitors Market?
Answer: Yes, Global PD-1 and PDL-1 Inhibitors Market report compares major players based on revenue, product portfolio, innovation, and regional presence. This helps assess competitive positioning.
6. Can I access country-level data within the Global PD-1 and PDL-1 Inhibitors Market report?
Answer: Yes, Global PD-1 and PDL-1 Inhibitors Market report includes detailed data by country, especially for key markets. This allows for localized insights and decision-making.
7. Can I get customized insights or data from the Global PD-1 and PDL-1 Inhibitors Market report?
Answer: Yes, we offer customization options to align with your specific business needs. You can request tailored sections or regional breakdowns.
🔐 Secure Payment Guaranteed
Safe checkout with trusted global payment methods.
🌟 Why Choose Infinity Market Research?
At Infinity Market Research, we dont just deliver data — we deliver clarity, confidence, and competitive edge.
In a world driven by insights, we help businesses unlock the infinite potential of informed decisions.
Here why global brands, startups, and decision-makers choose us:
Industry-Centric Expertise
With deep domain knowledge across sectors — from healthcare and technology to manufacturing and consumer goods — our team delivers insights that matter.
Custom Research, Not Cookie-Cutter Reports
Every business is unique, and so are its challenges. Thats why we tailor our research to your specific goals, offering solutions that are actionable, relevant, and reliable.
Data You Can Trust
Our research methodology is rigorous, transparent, and validated at every step. We believe in delivering not just numbers, but numbers that drive real impact.
Client-Centric Approach
Your success is our priority. From first contact to final delivery, our team is responsive, collaborative, and committed to your goals — because you re more than a client; you re a partner.
📄 Available License Types
